AL

Alan F. List

UA University Of Arizona: 2 patents #250 of 1,318Top 20%
UB U.S. Bioscience: 2 patents #4 of 16Top 25%
LB Lixte Biotechnology: 1 patents #8 of 15Top 55%
UF University Of South Florida: 1 patents #932 of 1,794Top 55%
📍 Tampa, FL: #84 of 2,931 inventorsTop 3%
🗺 Florida: #2,045 of 67,251 inventorsTop 4%
Overall (All Time): #189,798 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12319685 Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors Haitao Ji 2025-06-03
12077608 Stapled H2 pyrin peptides Haitao Ji 2024-09-03
11976104 TLR9 ligand trap Sheng Wei 2024-05-07
11584787 Soluble CD33 for treating myelodysplastic syndromes (MDS) Sheng Wei 2023-02-21
11361867 Pathways for treating patients Mark Gerard Schippits 2022-06-14
11286306 TLR9-binding chimeric antigen receptors Daniel Abate-Daga, Sheng Wei 2022-03-29
11287428 PD1 and PDL-1 expression during progression from myelodysplastic syndrome to acute myelogenous leukemia Sheng Wei 2022-03-29
11280787 Inflammasome activation in myelodysplastic syndromes 2022-03-22
11123435 TLR9 targeted therapeutics Sheng Wei, Mark McLaughlin 2021-09-21
10697970 S100A9 levels for predicting lenalidomide and erythropoietin responsiveness 2020-06-30
10688077 Inflammasome activation in myelodysplastic syndromes Sheng Wei 2020-06-23
10682417 Targeted sensitization of non-del(5q) malignant cells Sheng Wei 2020-06-16
10612097 RNF41 as a biomarker predicting response to lenalidomide in non-del(5q) MDS 2020-04-07
10488411 Inflammasome activation in myelodysplastic syndromes 2019-11-26
10434100 Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes David A. Sallman, John S. Kovach 2019-10-08
10344072 Soluble CD33 for treating myelodysplastic syndromes (MDS) Sheng Wei 2019-07-09
10071094 Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes David A. Sallman, John S. Kovach 2018-09-11
9956294 Targeted sensitization of non-del(5q) malignant cells Sheng Wei 2018-05-01
9738933 RNF41 as a biomarker predicting response to lenalidomide in non-del(5q) MDS 2017-08-22
9487776 Method of identifying myelodysplastic syndromes Lubomir Sokol 2016-11-08
5906984 Methods of using aminothiols to promote hematopoietic progenitor cell growth Robert L. Capizzi 1999-05-25
5846958 Methods of using aminothiols to promote hematopoietic progenitor cell growth Robert L. Capizzi 1998-12-08